EMA recommends suspension of 17-OHPC medicines in the EU

In some EU countries, 17-OHPC medicines have been authorized as injections for preventing pregnancy loss or premature birth. Credit: Victoria Moloman / Shutterstock.com. The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has advised the suspension of marketing authorizations for therapeutics containing 17-hydroxyprogesterone caproate (17-OHPC) in the European Union (EU). The recommendation follows a […]

7 mins read

Predictors of accessing seasonal malaria chemoprevention medicines through non-door-to-door distribution in Nigeria | Malaria Journal

Proportion of children receiving SMC medicines through non-DDD The final analytic sample included data from 24,003 caregivers of eligible children who received Day 1 SPAQ in the final cycle of SMC between 2021 and 2022 from Nigeria (Fig. 3). The proportion of children receiving SMC medicines but were not visited by CDs (non-DDD access to […]

8 mins read